CME ACTIVITY
Targeting the Pathophysiology of Type 2 Diabetes: The Emerging Role of Incretin-Based Therapies
Include proceedings from a symposium held during the 2008 Cardiometabolic Health Congress in Boston, Massachusetts
Activity Date: December 2008
Activity Info: Volume 8, (11)
 
 
 


Supported by an educational grant from
Novo Nordisk, Inc
 
 
     
 
Home | Contact Us | View Account | Need Help?